V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003968 | 280002894 | null | 92.3 | Palliative (P) | 2017-10-27 | 2017-11-07 | Carboplatin + Etoposide iv&po | 2 | N | 280026495 | CARBOPLATIN + ETOPOSIDE |
| 280003969 | 280002894 | null | 65 | Palliative (P) | 2015-12-16 | 2015-12-26 | CARBOPLATIN + ETOPOSIDE | N | N | 280026495 | CARBOPLATIN + ETOPOSIDE |
| 280003970 | 280002894 | 1.69 | 95.5 | Palliative (P) | 2015-05-09 | 2015-05-16 | EOX | null | null | 280026495 | EOX |
| 280003971 | 280002894 | 1.72 | 120 | Palliative (P) | 2017-10-10 | 2017-10-25 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280026495 | CISPLATIN + GEMCITABINE |
| 280003972 | 280002894 | 0 | null | Palliative (P) | 2017-05-15 | 2017-05-15 | DACTINOMYCIN + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | N | N | 280026495 | NOT MATCHED |
| 280003973 | 280002894 | 1.7 | 113 | Palliative (P) | 2013-09-06 | 2013-09-16 | CISPLATIN + GEMCITABINE | N | N | 280026495 | CISPLATIN + GEMCITABINE |
| 280003974 | 280002895 | 1.81 | 60.3 | Neo-adjuvant (N) | 2016-02-01 | 2016-02-13 | Carboplatin AUC 2 - 5 | 02 | null | 280026517 | CARBOPLATIN |
| 280003975 | 280002895 | 1.7 | 75 | Palliative (P) | 2015-03-18 | 2015-04-06 | Carboplatin + Etoposide iv&po | N | N | 280026517 | CARBOPLATIN + ETOPOSIDE |
| 280003976 | 280002895 | 1.72 | 70.2 | Palliative (P) | null | 2017-03-21 | CETUXIMAB | 02 | null | 280026517 | CETUXIMAB |
| 280003977 | 280002895 | 1.7 | 71.1 | Curative (C) | 2016-10-22 | 2016-11-03 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280026517 | CARBOPLATIN + PACLITAXEL |
| 280003978 | 280002895 | 0 | 50.5 | Palliative (P) | 2017-09-04 | 2017-09-06 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280026517 | NOT MATCHED |
| 280003979 | 280002896 | null | 86 | Palliative (P) | 2014-08-10 | 2014-08-11 | Carboplatin + Etoposide iv&po | 2 | N | 280026524 | CARBOPLATIN + ETOPOSIDE |
| 280003980 | 280002896 | 1.53 | 67 | Palliative (P) | 2017-03-10 | 2017-03-17 | Carboplatin AUC 6 - 10 | N | N | 280026524 | CARBOPLATIN |
| 280003981 | 280002897 | 1.22 | null | Palliative (P) | 2015-10-28 | 2015-10-29 | Trial Unspecified | 02 | null | 280026526 | TRIAL |
| 280003982 | 280002897 | 1.77 | null | Palliative (P) | 2014-03-07 | 2014-03-09 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280026526 | CISPLATIN + GEMCITABINE |
| 280003983 | 280002897 | 1.56 | 68 | Palliative (P) | null | 2016-12-09 | CARBOPLATIN + RT | null | null | 280026526 | CARBOPLATIN + RT |
| 280003984 | 280002897 | 1.65 | null | Palliative (P) | 2013-05-16 | 2013-05-27 | CISPLATIN + GEMCITABINE | 99 | null | 280026526 | CISPLATIN + GEMCITABINE |
| 280003985 | 280002898 | 1.58 | null | Palliative (P) | 2015-10-28 | 2015-11-29 | Carboplatin + Etoposide iv&po | null | N | 280026530 | CARBOPLATIN + ETOPOSIDE |
| 280003986 | 280002898 | null | 72.8 | Palliative (P) | 2014-11-24 | 2014-11-24 | Carboplatin AUC 6 - 10 | N | N | 280026530 | CARBOPLATIN |
| 280003987 | 280002898 | null | 51.8 | Palliative (P) | 2015-04-04 | 2015-04-04 | NB HRNBL-1 MOD N7 CAV | 01 | N | 280026530 | NOT MATCHED |
| 280003988 | 280002898 | 1.52 | 48.9 | Neo-adjuvant (N) | 2016-08-26 | 2016-08-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 280026530 | CISPLATIN + GEMCITABINE |
| 280003989 | 280002899 | 1.74 | 61.2 | Curative (C) | 2016-01-14 | 2016-01-30 | Cetuximab 7 day (Cycle 1) | 02 | N | 280026542 | CETUXIMAB |
| 280003990 | 280002899 | 1.73 | 14.3 | Palliative (P) | 2014-10-22 | 2014-11-14 | CETUXIMAB | 02 | N | 280026542 | CETUXIMAB |
| 280003991 | 280002899 | 0 | 88.8 | Curative (C) | null | 2016-12-14 | EW EuroEwing 2012 Arm B VDC | 02 | null | 280026542 | TRIAL |
| 280003992 | 280002899 | null | null | Palliative (P) | 2015-04-04 | 2015-04-30 | Carboplatin AUC 6 - 10 | Y | N | 280026542 | CARBOPLATIN |
| 280003993 | 280002900 | 1.67 | 70.1 | Palliative (P) | 2014-01-18 | 2014-01-27 | EOX | 2 | N | 280026551 | EOX |
| 280003994 | 280002900 | 1.17 | 12.8 | Palliative (P) | null | 2017-03-19 | STS Rhabdo RMS 2005 | 01 | null | 280026551 | NOT MATCHED |
| 280003995 | 280002901 | 1.7 | null | Palliative (P) | 2016-11-02 | 2016-11-10 | EOX | 02 | N | 280026553 | EOX |
| 280003996 | 280002901 | 1.53 | 63.3 | Palliative (P) | null | 2013-12-21 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280026553 | CARBOPLATIN + PACLITAXEL |
| 280003997 | 280002901 | 1.81 | 86.4 | Palliative (P) | 2016-11-13 | 2016-12-11 | Trial Unspecified | N | N | 280026553 | TRIAL |
| 280003998 | 280002902 | 1.47 | 56.7 | Palliative (P) | 2014-05-04 | 2014-05-20 | Trial Unspecified | N | N | 280026556 | TRIAL |
| 280003999 | 280002902 | 1.85 | 64.6 | Palliative (P) | 2015-07-11 | 2015-07-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 280026556 | CARBOPLATIN + PACLITAXEL |
| 280004000 | 280002902 | 1.99 | 85 | null | 2017-10-27 | 2017-11-10 | CETUXIMAB | Y | N | 280026556 | CETUXIMAB |
| 280004001 | 280010951 | 1.77 | 14.7 | Palliative (P) | 2014-10-25 | 2014-11-14 | CARBOPLATIN + RT | N | N | 280026563 | CARBOPLATIN + RT |
| 280004002 | 280010951 | 1.63 | 60.2 | Palliative (P) | 2014-08-02 | 2014-08-02 | CARBOPLATIN + RT | N | N | 280026563 | CARBOPLATIN + RT |
| 280004003 | 280002903 | 1.73 | 97.9 | null | 2017-08-30 | 2017-09-11 | CARBOPLATIN | 2 | N | 280026566 | CARBOPLATIN |
| 280004005 | 280002904 | null | 77 | Neo-adjuvant (N) | 2013-04-21 | 2013-05-01 | Cetuximab 7 day (Cycle 1) | N | N | 280026571 | CETUXIMAB |
| 280004006 | 280002904 | 1.69 | 70 | Palliative (P) | 2016-11-30 | 2016-12-14 | CETUXIMAB | 2 | N | 280026571 | CETUXIMAB |
| 280004007 | 280002904 | 0 | 75.1 | Palliative (P) | 2016-01-04 | 2016-01-05 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280026571 | NOT MATCHED |
| 280004008 | 280002905 | 1.64 | 74.7 | Palliative (P) | 2017-07-22 | 2017-07-22 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280026575 | CARBOPLATIN + ETOPOSIDE |
| 280004009 | 280002906 | 1.62 | 59.5 | Palliative (P) | 2015-07-15 | 2015-07-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 280026576 | CISPLATIN + GEMCITABINE |
| 280004010 | 280002906 | 1.52 | 82.4 | Curative (C) | 2017-04-17 | 2017-04-18 | EOX | Y | N | 280026576 | EOX |
| 280004011 | 280002907 | 1.7 | 70 | Palliative (P) | 2014-07-07 | 2014-07-10 | CARBOPLATIN + RT | N | N | 280026578 | CARBOPLATIN + RT |
| 280004012 | 280002908 | 0 | 94 | Palliative (P) | 2015-05-27 | 2015-05-28 | EW EuroEwing 2012 Arm B IE | N | N | 280026579 | TRIAL |
| 280004013 | 280002908 | 1.8 | 102 | Palliative (P) | 2014-11-24 | 2014-12-16 | Carboplatin AUC 6 - 10 | Y | N | 280026579 | CARBOPLATIN |
| 280004014 | 280002909 | 1.79 | 76 | Palliative (P) | 2017-01-01 | 2017-01-04 | CETUXIMAB | Y | N | 280026584 | CETUXIMAB |
| 280004015 | 280002909 | null | null | Palliative (P) | 2017-05-26 | 2016-05-15 | Cisplatin+Gemcitabine (gallbladder) | N | null | 280026584 | CISPLATIN + GEMCITABINE |
| 280004016 | 280002909 | 1.65 | null | Palliative (P) | 2016-09-19 | 2016-09-26 | Cetuximab 7 day (Cycle 1) | N | N | 280026584 | CETUXIMAB |
| 280004017 | 280002909 | 1.68 | 90.3 | Palliative (P) | 2017-01-02 | 2017-01-02 | CETUXIMAB | null | null | 280026584 | CETUXIMAB |
| 280004018 | 280002909 | 1.8 | 20.2 | Palliative (P) | 2014-12-13 | 2014-12-13 | EOX | N | N | 280026584 | EOX |